Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Exon skipping therapy for Duchenne muscular dystrophy.
Relationship between population density of attorneys and prevalence of methicillin-resistant Staphylococcus aureus: is medical-legal pressure on physicians a driving force behind the development of antibiotic resistance?
The influence of lipid droplet size on the oral bioavailability of vitamin D2 encapsulated in emulsions: an in vitro and in vivo study.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exon skipping therapy for Duchenne muscular dystrophy.
Kole R, Krieg AM. Exon skipping therapy for Duchenne muscular dystrophy. Adv Drug Deliv Rev. 2015 Jun 29; 87:104-7.
View in:
PubMed
subject areas
Animals
Dystrophin
Exons
Humans
Morpholinos
Muscular Dystrophy, Duchenne
Mutation
Oligonucleotides
Randomized Controlled Trials as Topic
RNA Splicing
authors with profiles
Arthur M Krieg MD